Akèy › Kansè nan tete › New York › New York City
Etid klinik pou Kansè nan tete nan New York City, NY
136 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote New York City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Ap rekriteFaz 1/2
- Research Site, New York
- Research Site, New York
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Ap rekriteFaz 3
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Irving Medical Center, New York
- ak 1 plis
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Ap rekrite
- Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities), New York
A Study of Mental Health Care in People With Cancer
Ap rekrite
- Memorial Sloan Kettering Cancer Center, New York
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
- Memorial Sloan Kettering Cancer Center, New York
A Study of PHST001 in Advanced Solid Tumors
Ap rekriteFaz 1
- Mount Sinai, New York
A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Ap rekriteFaz 1/2
- Columbia University Medical Center, New York
- Memorial Sloan Kettering, New York
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Ap rekriteFaz 3
- Mount Sinai School of Medicine, New York
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
Ap rekriteFaz 3
- Research Site, New York
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center, New York
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 2
- Memorial Sloan Kettering Hospital, New York
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
Ap rekriteFaz 1/2
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Ap rekriteFaz 1
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Ap rekriteFaz 1/2
- Memorial Sloan-Kettering Cancer Center, New York
A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Cancer
Ap rekrite
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
Ap rekriteFaz 2
- New York Proton Center, New York
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Ap rekriteFaz 1
- Research Site, New York
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
Ap rekriteFaz 3
- New York Proton Center, New York
Study of AVZO-021 in Patients With Advanced Solid Tumors
Ap rekriteFaz 1/2
- Avenzo Therapeutics Recruiting Site, New York
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Ap rekriteFaz 3
- Laura and Isaac Perlmutter Cancer Center-Hematology and Oncology ( Site 0068), New York
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Ap rekriteFaz 3
- Research Site, New York
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center, New York
A Study of Language Interpretation Solutions for People With Breast Cancer
Ap rekrite
- Memorial Sloan Kettering at Ralph Lauren Center (All Protocol Activities), New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer
Ap rekriteFaz 1
- Memorial Sloan Kettering Cancer Center, New York
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Ap rekrite
- NYU Langone Health, New York
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Ap rekriteFaz 3
- Clinical Trial Site, New York
- Clinical Trial Site, New York
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Ap rekriteFaz 1
- New York University (NYU) Langone Medical Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Ap rekriteFaz 1
- New York University (NYU) Clinical Cancer Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Ap rekriteFaz 3
- Memorial Sloan Kettering Cancer Center, New York
- NYC Health + Hospitals / Bellevue, New York
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center, New York
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
Ap rekriteVolontè an sante akeyi
- Weill Cornell Medicine, New York
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center, New York
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
Ap rekriteFaz 1/2
- Beth Israel Comprehensive Cancer Center, New York
- Mount Sinai Medical Center, New York
- Icahn School of Medicine at Mount Sinai PRIME, New York
- ak 2 plis
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Ap rekriteFaz 3
- Paradigm New York Cancer and Blood Specialists, New York
- Paradigm New York Cancer and Blood Specialists, New York
- Paradigm New York Cancer and Blood Specialists, New York
- ak 5 plis
A Study of Breast Cancer Risk Factors and Outcomes of People in Florida
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Memorial Sloan Kettering Cancer Center (All protocol activites), New York
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Ap rekriteFaz 3
- The Blavatnik Family - Chelsea Medical Center at Mount Sinai, New York
- Laura and Isaac Perlmutter Cancer Center/NYU Langone Health, New York
- Mount Sinai West, New York
- ak 2 plis
A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer
Ap rekriteFaz 1
- Memorial Sloan Kettering Cancer Center (All protocol activites), New York
A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Ap rekriteFaz 1
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Ap rekriteFaz 1
- Icahn School of Medicine at Mount Sinai, New York
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
Ap rekriteFaz 1
- Chelsea Medical Center at Mount Sinai, New York
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Ap rekriteFaz 1/2
- NYU Langone Health Perlmutter Cancer Center, New York
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Ap rekriteFaz 1
- New York University (NYU) Clinical Cancer Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Ap rekriteFaz 3
- The Blavatnik Family ? Chelsea Medical Center at Mount Sinai, New York
- Mount Sinai West, New York
- Icahn School of Medicine at Mount Sinai, New York
- ak 1 plis
Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors
Ap rekriteEtid obsèvasyon
- Memorial Sloan Kettering Cancer Center, New York
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Ap rekriteFaz 3
- Manhattan Hematology /Oncology Associates, New York
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C (NY), New York
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Ap rekriteFaz 3
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Manhattan Eye Ear and Throat Hospital, New York
- ak 2 plis
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Ap rekrite
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Study of Aerobic Training for People Receiving Treatment for Breast Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Ap rekriteFaz 1
- New York Cancer & Blood Specialists, New York
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
Ap rekriteFaz 1/2
- Memorial Sloan Kettering, New York
A Study of Romosozumab in People With Breast Cancer and Osteoporosis
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center, New York
HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
ATEMPT 2.0: Adjuvant T-DM1 vs TH
Ap rekriteFaz 2
- New York University Langone Health, New York
- Northwell University, New York
Decision Support Tool for Patients With Advanced Breast Cancer
Ap rekrite
- NewYork-Presbyterian David H. Koch Center, New York
Optimizing Surgical Decisions in Young Adults With Breast Cancer
Ap rekrite
- Weill Cornell Medicine, New York
A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer
Ap rekriteFaz 2
- Memorial Sloan-Kettering Cancer Center (All Protocol Activities), New York
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Ap rekriteFaz 3
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- New York Proton Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer
Ap rekriteFaz 2
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
Medical Imaging and Focused Ultrasound Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI)
Ap rekriteFaz 1
- Columbia University Irving Medical Center/NYP, New York
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Ap rekriteFaz 2/3
- Memorial Sloan Kettering Cancer Center, New York
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Ap rekriteFaz 3
- New York-Presbyterian - Columbia University Irving Medical Center, New York
E-Mindfulness Approaches for Living After Breast Cancer
Ap rekriteFaz 3
- Mount Sinai Union Square, New York
- Mount Sinai Chelsea, New York
- Mount Sinai West, New York
- ak 1 plis
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
Ap rekrite
- Memorial Sloan Kettering Cancer Center, New York
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
Ap rekrite
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
Ap rekriteVolontè an sante akeyi
- Memorial Sloan Kettering Cancer Center, New York
A Study of a Side Effects and Resource Navigation Program for People With Cancer
Ap rekrite
- City College of New York (Data Collection AND Specimen Analysis), New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Adherence Intervention in Patients With Metastatic Breast Cancer
Ap rekrite
- Columbia University Medical Center, New York
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Ap rekriteFaz 2
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Radiation After No Axillary Nodal Sampling
Ap rekrite
- NYU Langone Health, New York
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
- Investigative Site #103, New York
- Investigative Site #106, New York
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- Memorial Sloan Kettering Cancer Center 53rd street., New York
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
Ap rekriteFaz 4
- Weill Cornell Medicine, New York
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
Ap rekrite
- NYU Langone Health, New York
- Columbia University Medical Center, New York
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement
Ap rekriteFaz 4
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
Opioid Dispensing Device for Post-Operative Pain in Cancer Patients
Ap rekrite
- Columbia University Medical Center, New York
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center, New York
A Study of a Decision Tool for People Considering Breast Reconstruction Surgery
Ap rekrite
- Memorial Sloan Kettering Cancer Center, New York
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Cancer Center, New York
A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Ap rekriteFaz 1/2
- New York University Langone Health, New York
- ICHAN School of Medicine at Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Ap rekriteFaz 3
- The Blavatnik Family - Chelsea Medical Center at Mount Sinai, New York
- Icahn School of Medicine at Mount Sinai, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Two Versus One Week Breast Radiotherapy (RT)
Ap rekriteFaz 3
- Brooklyn Methodist Hospital, New York
- New York Presbyterian Hospital, New York
- New York-Presbyterian Weill Cornell Medical College, New York
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job
Ap rekrite
- Bellevue Hospital Center (Data Collection Only), New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs
Ap rekrite
- VA New York Harbor Health Care System - Manhattan, New York
- VA New York Harbor Healthcare System - Harlem Community Center, New York
Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients
Ap rekriteEtid obsèvasyon
- Memorial Sloan-Kettering Cancer Center, New York
A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery
Ap rekrite
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer
Ap rekriteFaz 1
- Memorial Sloan Kettering Cancer Center (All protocol activites), New York
Elacestrant in Advanced Triple Positive Breast Cancer
Ap rekriteFaz 1/2
- NYU Langone Health, New York
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Ap rekriteFaz 3
- Weill Cornell Medical College - NewYork-Presbyterian Hospital, New York
A Study of Blood Pressure Control During Cancer Treatment
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer
Ap rekriteFaz 1 bonè
- Mount Sinai Health System, New York
A Study of Surgery and Radiotherapy in People With Breast Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center (All protocol activites), New York
Brodalumab in the Treatment of Immune-Related Adverse Events
Ap rekriteFaz 1
- Columbia University Irving Medical Center, New York
Lymphedema Surveillance Study
Ap rekriteEtid obsèvasyon
- Memorial Sloan Kettering Cancer Center, New York
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Ap rekriteFaz 2
- Laura and Isaac Perlmutter Cancer Center / NYU Langone Health, New York
- Columbia University Medical Center, New York
IMPACT Trial: Intervention to iMProve AdherenCe Equitably
Ap rekrite
- Columbia University Medical Center, New York
Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial
Ap rekriteFaz 2
- Weill Cornell Medicine, New York
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Ap rekriteFaz 3
- Mount Sinai Union Square, New York
- Mount Sinai Chelsea, New York
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- ak 5 plis
Factors Associated With Breast Cancer Risks and Outcomes
Ap rekriteEtid obsèvasyon
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
Ap rekrite
- The New York Proton Center, New York
Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer
Ap rekriteFaz 1/2Volontè an sante akeyi
- Mount Sinai Beth Israel, New York
- Mount Sinai - West, New York
- Dubin breast Center, New York
Breast Cancer Implementation Science Study With Educational Intervention
Ap rekrite
- NYU Langone Health, New York
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
Ap rekriteFaz 1/2
- Weill Cornell Medicine, New York
- Brooklyn Methodist Hospital - NewYork Presbyterian, New York
- New York Presbyterian Hospital - Queens, New York
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Ap rekriteFaz 1/2
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Weill Cornell Medicine of Cornell University, New York
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
Ap rekriteEtid obsèvasyon
- Memorial Sloan Kettering Cancer Center, New York
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center, New York
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Ap rekriteFaz 1
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
Ap rekrite
- Columbia University Irving Medical Center, New York
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
Ap rekriteFaz 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of Revaree Plus in People With Breast Cancer
Ap rekriteFaz 4
- Memorial Sloan Kettering Cancer Center, New York
SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
Ap rekriteFaz 1
- Memorial Sloan Kettering Cancer Center, New York
Converting HR+ Breast Cancer Into an Individualized Vaccine
Ap rekriteFaz 2
- New York Presbyterian Hospital - Queens, New York
- Weill Cornell Medicine New York Presbyterian Hospital, New York
- Brooklyn Methodist Hospital - NewYork Presbyterian, New York
Personalized Second Chance Breast Conservation (PSCBC): A Prospective Phase II Clinical Study
Ap rekrite
- New York Presbyterian Hospital - Queens, New York
- Weill Cornell Medicine, New York
Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol
Ap rekriteFaz 4
- Memorial Sloan Kettering Cancer Center, New York
De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You
Ap rekriteEtid obsèvasyon
- Brooklyn Methodist Hospital - NewYork Presbyterian, New York
- New York Presbyterian Hospital - Queens, New York
Combined Immunotherapies in Metastatic ER+ Breast Cancer
Ap rekriteFaz 2
- Weill Cornell Medicine, New York
- Brooklyn Methodist Hospital - NewYork Presbyterian, New York
- New York Presbyterian Hospital - Queens, New York
Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer
Ap rekriteFaz 4
- New York-Presbyterian/Weill Cornell Medical Center, New York
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
Ap rekriteFaz 3
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Enhancing Access to Supportive Services for Women of Color With Metastatic Breast Cancer
Ap rekrite
- Mount Sinai Hospital, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, New York
Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)
Ap rekriteEtid obsèvasyon
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Memorial Sloan Kettering Cancer Center, New York
The Cancer of the Pancreas Screening-5 CAPS5)Study
Ap rekriteFaz 3
- NYU Langone Medical Center, New York
- Columbia University Medical Center, New York
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
Ap rekriteFaz 1
- NYU Langone, New York
- Columbia University Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering, New York
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
Ap rekriteFaz 1
- Exelixis Clinical Site #5, New York
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Ap rekriteEtid obsèvasyon
- Kings County Hospital, New York
Breast Elasticity Imaging During Neoadjuvant Chemotherapy
Ap rekrite
- Columbia University Irving Medical Center/NYP, New York
Comprehensive Outcomes for After Cancer Health
Ap rekriteVolontè an sante akeyi
- Memorial Sloan Kettering Cancer Center, New York
Etid Kansè nan tete nan lòt vil
- Houston, TX126 etid
- Boston, MA112 etid
- Nashville, TN81 etid
- Los Angeles, CA73 etid
- Edison, NJ68 etid
- St. Louis, MO64 etid
- Queens, NY64 etid
- Durham, NC64 etid
- Chicago, IL59 etid
- Philadelphia, PA56 etid
- Dallas, TX55 etid
- Arlington, VA47 etid
Lòt etid nan New York City
- Kansè Poumon ki pa ti selil121 etid
- Kansè (tout kalite)109 etid
- Kansè pwostat103 etid
- Kansè Metastatik93 etid
- Kansè kolorektal78 etid
- Kansè ovè69 etid
- Kansè poumon60 etid
- Myelom Miltip60 etid
- Kansè pankreyas60 etid
- Kansè Endomèt52 etid
- Leksemi mieloïd egi51 etid
- Ensifizyans kadyak51 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.